Medical College of Georgia

  CB&A Home

A-Z Index  |  MCG Home  |  Site Search      
     
Faculty
Staff and Fellows
CB&A Graduate Program
Graduate Students
Graduate Studies Program
Anatomical Donations

 
 

 

Sally S. Atherton, Ph.D.
 satherton@mcg.edu

Telephone: 706.721.3731
Fax: 706.721.6120
Room: CB-1109

Regents Professor and Chair,

Department of Cellular Biology and Anatomy

Joint Professor, Department of Ophthalmology

Member and Chair of the Research Centers in Minority Institutions (RCMI) study section; ad hoc reviewer for Visual Sciences A and Visual Sciences C study sections

Trustee, Immunology and Microbiology section of the Association for Research in Vision and Ophthalmology (ARVO)

Editorial Board, Experimental Eye Research

 

Education and Training:
1970 B.A., Biology, Colby College, Waterville, ME
1973 M.S., Biology, Trinity University, San Antonio, TX
1979 Ph.D., Microbiology, University of Texas Health Science Center, San Antonio, TX

Postdoctoral Training:

1979-1981 - Molecular Virology, University of Mississippi Medical Center, Jackson, MS
1981-1984 - Immunology, University of Texas Southwestern Medical School

 

Research Emphasis:
        I am interested in elucidating the immunologic and virologic mechanisms of ocular virus infections.  The overall goal of the studies in my laboratory is to extrapolate findings from animal models to what is observed clinically in human patients and in so doing, to be able to understand the pathogenesis of human ocular diseases.  Current projects require expertise not only in immunology and virology, but also in neuroanatomy and cell biology, and consequently, projects in my laboratory employ a variety of cell biology, immunology, virology, and molecular biology techniques.
        There are two primary research projects in my laboratory and both of these projects are supported by grants from the National Eye Institute of the National Institutes of Health.  Acute retinal necrosis (ARN) caused by several neurotropic members of the herpes virus family (HSV-1, HSV-2, VZV) occurs in immunocompetent human patients.  Individuals afflicted with ARN experience acute retinitis which frequently results in loss of vision in the affected eye.  We study a mouse model of the human disease in which immunocompetent BALB/c mice are infected intraocularly with HSV-1.  Following injection, virus is transmitted via neuronal routes from the injected eye through the CNS to the optic nerve and retina of the uninjected eye resulting in acute retinitis followed by retinal necrosis.  We are using the mouse model of ARN to determine what prevents direct anterior to posterior spread following infection of the anterior segment, what mechanism prevents virus that has spread to the brain from infecting the optic nerve of the virus-infected eye, and the role of T cells and cytokines during virus infection of the uninoculated eye.
         Cytomegalovirus (CMV) retinitis is the most common infectious ocular complication of AIDS and a significant cause of morbidity and increased mortality among patients who have received a bone marrow transplant.  The other project in my laboratory uses a model of CMV retinitis in which immunosuppressed mice are infected with murine CMV (MCMV) to answer questions about the pathogenesis of CMV retinitis.  The aims of our current project are to define the sites of latency in the eye and whether the route which is used for ocular infection determines the sites at which virus will become latent, to determine if MCMV can spread to and replicate in the retina of immunosuppressed mice following disruption of the blood-ocular barrier, and to determine the mechanism by which MCMV infection of the retinal pigment epithelium results in apoptosis of the overlying retina. 

RESEARCH GOALS: The overall goal of our research is to elucidate the pathogenesis of herpes virus infections of the eye and brain. A mouse model of herpes simplex virus type 1 (HSV-1) retinitis is used to study neuronal spread of virus within the eye and brain, to decipher the components of the innate and adaptive immune responses that influence the timing and sites of virus spread and replication during acute infection, and to study the effect of cytokine-expressing recombinant viruses on the pathogenesis of CNS and retinal infection. To complement the mouse studies, studies of human ganglia are used to identify autonomic ganglia in the head and neck that are sites of herpes virus latency (HSV-1, HSV-2, and VZV). Cytomegalovirus retinitis is the most common opportunistic ocular infection in patients with the acquired immune deficiency syndrome. A mouse model of this disease is used to determine how and when virus infects the eye, which retinal cells are infected, the role of macrophages and other effector cells in control of virus spread, and the sites and timing of virus reactivation in immunologically manipulated animals.
APPROACHES: To address the above research goals, we use techniques ranging from the molecular to the whole animal. Techniques used most frequently are: collection, preparation, and examination of human and mouse tissues, in vivo immunological manipulation, RT-PCR, TUNEL and caspase assays, DNA laddering, construction of cytokine-expressing recombinant viruses, culture of primary cells and of established cell lines, immunohistochemistry, and confocal microscopy.
FUNDING: National Institutes of Health and unrestricted research funds
RECENT PUBLICATIONS:
Archin NM, van den Boom L, Perelygina L, Hilliard JM, Atherton SS. 2003. Delayed spread and reduction in virus titer after anterior chamber inoculation of a recombinant of HSV-1 expressing IL-16. Invest Ophthalmol Vis Sci. 44:3066-3076.
Zhang, M., Xin, H., Duan, Y., and Atherton, S.S. 2005. Ocular reactivation of MCMV following immunosuppression of latently infected BALB/c mice. Invest. Ophthalmol. Vis. Sci. 46:252-258.
Zheng, M. and Atherton, S.S. 2005. Cytokine profiles and inflammatory cells during HSV-1 induced acute retinal necrosis. Invest. Ophthalmol. Vis. Sci. 46:1356-1363.
Zhang, M., Xin, H., and Atherton, S.S. Murine cytomegalovirus spreads to and replicates in the retina after endotoxin disruption of the blood-retinal barrier of immunosuppressed BALB/c mice. J. Neurovirol., In press.

 

Selected Publications:

Zhao, M. and Atherton, S.S. 1997.  Immune effector cell (IEC)-mediated protection from HSV-1 retinitis occurs in the brain.  J. Neuroimmunol. 75:51-58.

Matsubara, S. and Atherton, S.S. 1997.  T cell depletion correlates with early spread of HSV-1 to the suprachiasmatic nucleus.  J. Neuroimmunol. 80:165-171.

Bigger, J.E., Thomas, C.A., and Atherton, S.S.  1998.  Natural killer cell modulation of MCMV retinitis.  J. Immunol. 160:5826-5831.

Tanigawa, M., Bigger, J.E., Kanter, M.Y., and Atherton, S.S. 2000.  Natural killer cells prevent direct anterior-to-posterior spread of herpes simplex virus type 1 in the eye.  Invest. Ophthalmol. Vis. Sci. 41:132-137.

Bigger, J.E., Tanigawa, M., Zhang, M., and Atherton, S.S. 2000.  Murine cytomegalovirus infection causes apoptosis of uninfected retinal cells.  Invest. Ophthalmol. Vis. Sci. 41:2248-2254.

 

Return to Top of Page
 


© Medical College of Georgia
All rights reserved

Cellular Biology and Anatomy
School of Medicine  |  School of Graduate Studies

Please email comments, suggestions or questions to:
Nan Eaton,
neaton@mcg.edu

May 23, 2007